Marksans Pharma Limited has informed the Exchange about Schedule of a conference call for analysts and investors on Friday, November 14, 2025 at 05:00 PM (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2025.
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has scheduled a conference call for analysts and investors on Friday, November 14, 2025, at 05:00 PM IST. The call will cover the unaudited financial results (both standalone and consolidated) for the quarter and half year ended September 30, 2025, i.e., Q2 and H1 FY26 earnings. This is a standard post-results interaction where management typically walks through performance, key business updates, and may field questions from analysts. No actual financial numbers have been shared in this filing — only the date and agenda for the call.
This is a routine corporate communication and not an event-driven announcement, so it should have little to no direct impact on the stock price. Investors should watch the call for management commentary on margins, US business, and guidance, which could shape near-term sentiment.